Hepatic clearance of endotoxins: differences in arterial and portal venous infusion.

Endotoxaemia as a cause of fever in immunosuppressed patients. J Clin Pathol (1984) 0.91

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med (2001) 44.67

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22. J Clin Oncol (1997) 1.56

Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis. Scand J Gastroenterol (1976) 1.54

On the pathogenesis of galactosamine hepatitis. Indications of extrahepatocellular mechanisms responsible for liver cell death. Virchows Arch B Cell Pathol (1978) 1.46

Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med (1981) 1.45

Mithramycin treatment of hypercalcemia. Cancer (1970) 1.38

Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial. J Clin Oncol (1986) 1.17

A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group. Cancer (1997) 1.09

Lactulose--a drug with antiendotoxin effect. Hepatogastroenterology (1980) 1.09

Letter: Endotoxaemia in liver cirrhosis: treatment with polymyxin B. Lancet (1975) 1.03

Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents. Cancer Treat Rep (1981) 1.01

Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial. Cancer (1990) 0.98

Virus-binding activity of fibronectin: masking of hepatitis A virus. J Virol Methods (1984) 0.97

[Peliosis hepatis. A clinical status inventory]. Z Gastroenterol (1982) 0.96

Clinical study with bleomycin. Cancer (1971) 0.94

Significance of endotoxaemia in experimental "galactosamine-hepatitis" in the rat. Acta Hepatogastroenterol (Stuttg) (1977) 0.94

Nicotianamine and the distribution of iron into the apoplasm and symplasm of tomato (Lycopersicon esculentum Mill.) : I. Determination of the apoplasmic and symplasmic iron pools in roots and leaves of the cultivar Bonner Beste and its nicotianamine-less mutant chloronerva. Planta (1992) 0.94

Synthesis of spherical porous silicas in the micron and submicron size range: challenges and opportunities for miniaturized high-resolution chromatographic and electrokinetic separations. J Chromatogr A (2000) 0.94

Determination of ascorbic acid in algae by high-performance liquid chromatography on strong cation-exchange resin with electrochemical detection. Anal Biochem (1983) 0.89

Modulation of mu opioid receptor desensitization in peripheral sensory neurons by phosphoinositide 3-kinase gamma. Neuroscience (2010) 0.89

Mithramycin therapy in disseminated germinal testicular cancer. JAMA (1968) 0.88

Management of carcinoid syndrome. Med Pediatr Oncol (1979) 0.88

Influence of liver-RES on toxic liver damage due to galactosamine. Acta Hepatogastroenterol (Stuttg) (1974) 0.88

[Endotoxinemia in liver cirrhosis]. Z Gastroenterol (1976) 0.87

Endotoxin-induced liver necrosis and intravascular coagulation in rats enhanced by portacaval collateral circulation. Gut (1975) 0.87

Effects of tamoxifen treatment on plasma lipids and lipoprotein lipid composition. J Clin Endocrinol Metab (1990) 0.86

Results with methyl-CCNU and DTIC in metastatic melanoma. Cancer (1977) 0.86

Detection of a non-A, non-B hepatitis associated substance in stools. Dev Biol Stand (1983) 0.85

[Sirenomelia--prenatal diagnosis and clinical consequences of a rare abnormality]. Z Geburtshilfe Neonatol (1998) 0.84

Influence of clinical parameters on the results of 13C-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil (2009) 0.83

Comparison of doxorubicin with cycloleucine in the treatment of sarcomas. Cancer Treat Rep (1981) 0.83

Neoplastic surface changes in urothelium of rats after portacaval anastomosis. A combined light and scanning electron microscopic study. Exp Pathol (1984) 0.83

In vivo and electron microscopic observations of the hepatic microvasculature in the rat following portacaval anastomosis. Hepatology (1983) 0.83

Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy. Breast Cancer Res Treat (1983) 0.82

Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation. J Clin Oncol (1994) 0.81

[Manganese deficiencies in ruminants. 5. Effect of manganese deficiency on the content of major and trace elements in adult male and female goats]. Arch Tierernahr (1973) 0.81

[Endotoxins and RES function in pathogenesis of liver diseases]. Internist (Berl) (1976) 0.80

[Cavernous transformation of the portal vein causing bile drainage disturbance (author's transl)]. Leber Magen Darm (1980) 0.80

Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: preliminary study. Osteoporos Int (1991) 0.80

Endotoxins and the pathogenesis of hepatic and gastrointestinal diseases. Ergeb Inn Med Kinderheilkd (1982) 0.80

Treatment of posttransplant lymphoproliferative disorder with the anti-CD20 monoclonal antibody rituximab alone in an adult after liver transplantation: a new drug in therapy of patients with posttransplant lymphoproliferative disorder after solid organ transplantation? Transplantation (2000) 0.80

Bladder carcinogenesis in portacaval shunt rats. Urol Int (1987) 0.80

Sensorimotor representation and knowledge-based reasoning for spatial exploration and localisation. Cogn Process (2008) 0.80

Hepatic blood flow in rats with galactosamine hepatitis. Acta Hepatogastroenterol (Stuttg) (1973) 0.79

Ultrastructural characteristics of hyperplastic alterations in the liver of congenital portacaval-shunt rats. Br J Exp Pathol (1984) 0.79

[Alpha 1-antitrypsin deficiency and the liver (author's transl)]. Z Gastroenterol (1982) 0.79

Endotoxaemia in acute hepatic failure. Acta Hepatogastroenterol (Stuttg) (1976) 0.79

Hepatic blood flow and cardiac output after porta-caval anastomosis in the rat. Acta Hepatogastroenterol (Stuttg) (1976) 0.79

[Hepatitis non-A, non-B-associated substance in stool from patients with posttransfusion and sporadic hepatitis]. Immun Infekt (1988) 0.79

[Determination of the intravascular distribution space in the rat]. Arzneimittelforschung (1973) 0.78

Chemistry, occurrence and biosynthesis of C-glycosyl compounds in plants. Planta Med (1983) 0.78

Liver volume influences early outcome after portacaval anastomosis. Acta Gastroenterol Belg (1979) 0.78

Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma. Clin Pharmacol Ther (1972) 0.78

[Endotoxinemia in acute pancreatitis (author's transl)]. Leber Magen Darm (1980) 0.78

Biological consequences of porta-caval collateral circulation. Significance of pancreatic venous blood. Acta Hepatogastroenterol (Stuttg) (1978) 0.78

Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma. Cancer (1976) 0.78

Some nematodes and acanthocephalans from exotic ornamental freshwater fishes imported into Germany. Folia Parasitol (Praha) (1999) 0.77

Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer. Cancer Treat Rep (1979) 0.77

Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma. Cancer Treat Rep (1980) 0.77

The lead status of horses from central Europe depending on breed, sex, age and living area. Arch Tierernahr (1989) 0.77

[Hepatitis non-A, non-B-associated DNA--demonstration of DNA in proven infectious anti-D-immunoglobulin]. Immun Infekt (1988) 0.77

[Etiology, complications and prognosis of liver cirrhosis in 917 patients. II. Causes of death and prognosis in liver cirrhosis]. Lebensversicher Med (1979) 0.77

Nickel--an essential element. IARC Sci Publ (1984) 0.77

[Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)]. Z Gastroenterol (1978) 0.77

[Nickel--an essential trace element. 1. Influence of the supply of nickel on live weight gains, food consumption and body composition of growing pigs and goats]. Arch Tierernahr (1977) 0.76

[Endotoxins and the pathogenesis of gastrointestinal diseases (author's transl)]. MMW Munch Med Wochenschr (1981) 0.76

Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents. Vaccine (2005) 0.76

Megestrol acetate as primary hormonal therapy for advanced breast cancer. Semin Oncol (1988) 0.76

Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen. Semin Oncol (1988) 0.76

Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea. Cancer (1972) 0.76

Phase II trial adriamycin and cis-dichlorodiammineplatinum(II) in squamous cell, ovarian, and testicular carcinomas. Cancer Treat Rep (1978) 0.76

[Autoradiographic studies in experimental brain concussion]. Arch Psychiatr Nervenkr (1970) (1970) 0.76

[Polymyxin B treatment of endotoxinemia in liver cirrhosis]. Verh Dtsch Ges Inn Med (1978) 0.75

Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels. Semin Oncol (1985) 0.75

[Hypovolaemia and haemoconcentration in rats with galactosamine-induced hepatitis]. Klin Wochenschr (1972) 0.75

[Effect of a choline-deficient diet on drug metabolism in the rat in vivo and in vitro]. Verh Dtsch Ges Inn Med (1974) 0.75

[Effects of porto-caval end-to-side-anastomosis on the liver of rats (author's transl)]. Z Gastroenterol (1977) 0.75

Regulation of fibrinogen synthesis in portal hypertension. Thromb Diath Haemorrh (1974) 0.75

[Consumption coagulopathy in toxic liver lesions due to Amanita phalloides poisoning]. Dtsch Med Wochenschr (1972) 0.75

[Significance of liver volume for the early survival of patients with liver cirrhosis operated on porta-caval anastomosis: Clinical data and relation to pathophysiological implications (author's transl)]. Med Klin (1977) 0.75

[Modified portacaval anastomosis in the rat (mPCA). Clinical studies on the pathogenesis of the Eck fistula syndrome]. Verh Dtsch Ges Inn Med (1978) 0.75

Galactosamine- "hepatitis" in rats with different phagocytic activity of liver RES. Acta Hepatogastroenterol (Stuttg) (1975) 0.75

[Effect of severe liver diseases on the central nervous system]. Med Klin (1977) 0.75

[Morphological investigations of extrahepatic disorders after porta-caval end-to-side-anastomosis in rats (author's transl)]. Z Gastroenterol (1977) 0.75

[Systemic hemodynamics and blood coagulation in portal hypertension. Pathophysiologic and therapeutic aspects]. Med Klin (1977) 0.75